FDA·Medicines·September 23, 2026

Inventia Healthcare recalls Chlorthalidone Tablets, USP, 25 mg over failed dissolution specifications

The notice says these chlorthalidone tablets failed dissolution specifications, and it covers 13567 bottles of 100 tablets sold across the U.S.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Hazard
Failed Dissolution Specifications
Units
13567 bottles
Where sold
U.S. Nationwide
FDA classification
Class II · Ongoing
Classified by FDA
September 17, 2026
Recall started
September 3, 2026
FDA enforcement report
September 23, 2026
Identifiers
  • Codes: Batch # RISA24002; Exp Date: 04/2027
  • FDA recall number: D-0852-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Reason for recall
Failed Dissolution Specifications
Classification
Class II (Ongoing)
Distribution
U.S. Nationwide
Quantity
13567 bottles

Related recalls